乗り物酔い治療薬の世界市場2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Motion Sickness Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D0GIR-00312 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、乗り物酔い治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。乗り物酔い治療薬の種類別市場規模（抗コリン薬、抗ヒスタミン剤、その他）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：GlaxoSmithKline、Reliefband Technologies、WellSpring Pharmaceutical Corporation、Perrigo Company、Baxter International、Prestige Brands、Myungmoon Pharm、Caleb Pharmaceuticals ・地域別グローバル市場分析 2015年-2020年 ・乗り物酔い治療薬の北米市場（アメリカ、カナダ、メキシコ） ・乗り物酔い治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・乗り物酔い治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・乗り物酔い治療薬の南米市場（ブラジル、アルゼンチン） ・乗り物酔い治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：抗コリン薬、抗ヒスタミン剤、その他 ・用途別分析：病院、クリニック、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The global Motion Sickness Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.3% in the forecast period of 2020 to 2025 and will expected to reach USD 622.1 million by 2025, from USD 568.1 million in 2019.

The Motion Sickness Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Motion Sickness Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Motion Sickness Treatment market has been segmented into:
Anticholinergic
Antihistamines
Others

By Application, Motion Sickness Treatment has been segmented into:
Hospitals
Clinics
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Motion Sickness Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Motion Sickness Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Motion Sickness Treatment market.

The report offers in-depth assessment of the growth and other aspects of the Motion Sickness Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Motion Sickness Treatment Market Share Analysis
Motion Sickness Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Motion Sickness Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Motion Sickness Treatment sales, revenue and market share for each player covered in this report.

The major players covered in Motion Sickness Treatment are:
GlaxoSmithKline
Reliefband Technologies
WellSpring Pharmaceutical Corporation
Perrigo Company
Baxter International
Prestige Brands
Myungmoon Pharm
Caleb Pharmaceuticals

レポート目次

---

Table of Contents

1 Motion Sickness Treatment Market Overview
1.1 Product Overview and Scope of Motion Sickness Treatment
1.2 Classification of Motion Sickness Treatment by Type
1.2.1 Global Motion Sickness Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Motion Sickness Treatment Revenue Market Share by Type in 2019
1.2.3 Anticholinergic
1.2.4 Antihistamines
1.2.5 Others
1.3 Global Motion Sickness Treatment Market by Application
1.3.1 Overview: Global Motion Sickness Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Motion Sickness Treatment Market by Regions
1.4.1 Global Motion Sickness Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Motion Sickness Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Motion Sickness Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Motion Sickness Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Motion Sickness Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Motion Sickness Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Motion Sickness Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GlaxoSmithKline SWOT Analysis
2.1.4 GlaxoSmithKline Product and Services
2.1.5 GlaxoSmithKline Motion Sickness Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Reliefband Technologies
2.2.1 Reliefband Technologies Details
2.2.2 Reliefband Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Reliefband Technologies SWOT Analysis
2.2.4 Reliefband Technologies Product and Services
2.2.5 Reliefband Technologies Motion Sickness Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 WellSpring Pharmaceutical Corporation
2.3.1 WellSpring Pharmaceutical Corporation Details
2.3.2 WellSpring Pharmaceutical Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 WellSpring Pharmaceutical Corporation SWOT Analysis
2.3.4 WellSpring Pharmaceutical Corporation Product and Services
2.3.5 WellSpring Pharmaceutical Corporation Motion Sickness Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Perrigo Company
2.4.1 Perrigo Company Details
2.4.2 Perrigo Company Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Perrigo Company SWOT Analysis
2.4.4 Perrigo Company Product and Services
2.4.5 Perrigo Company Motion Sickness Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Baxter International
2.5.1 Baxter International Details
2.5.2 Baxter International Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Baxter International SWOT Analysis
2.5.4 Baxter International Product and Services
2.5.5 Baxter International Motion Sickness Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Prestige Brands
2.6.1 Prestige Brands Details
2.6.2 Prestige Brands Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Prestige Brands SWOT Analysis
2.6.4 Prestige Brands Product and Services
2.6.5 Prestige Brands Motion Sickness Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Myungmoon Pharm
2.7.1 Myungmoon Pharm Details
2.7.2 Myungmoon Pharm Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Myungmoon Pharm SWOT Analysis
2.7.4 Myungmoon Pharm Product and Services
2.7.5 Myungmoon Pharm Motion Sickness Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 Caleb Pharmaceuticals
2.8.1 Caleb Pharmaceuticals Details
2.8.2 Caleb Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Caleb Pharmaceuticals SWOT Analysis
2.8.4 Caleb Pharmaceuticals Product and Services
2.8.5 Caleb Pharmaceuticals Motion Sickness Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Motion Sickness Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Motion Sickness Treatment Players Market Share
3.2.2 Top 10 Motion Sickness Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Motion Sickness Treatment Revenue and Market Share by Regions
4.2 North America Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
5 North America Motion Sickness Treatment Revenue by Countries
5.1 North America Motion Sickness Treatment Revenue by Countries (2015-2020)
5.2 USA Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
6 Europe Motion Sickness Treatment Revenue by Countries
6.1 Europe Motion Sickness Treatment Revenue by Countries (2015-2020)
6.2 Germany Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
6.4 France Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Motion Sickness Treatment Revenue by Countries
7.1 Asia-Pacific Motion Sickness Treatment Revenue by Countries (2015-2020)
7.2 China Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
7.5 India Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
8 South America Motion Sickness Treatment Revenue by Countries
8.1 South America Motion Sickness Treatment Revenue by Countries (2015-2020)
8.2 Brazil Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Motion Sickness Treatment by Countries
9.1 Middle East & Africa Motion Sickness Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Motion Sickness Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Motion Sickness Treatment Market Forecast by Type (2019-2024)
10.3 Anticholinergic Revenue Growth Rate (2015-2025)
10.4 Antihistamines Revenue Growth Rate (2015-2025)
10.5 Others Revenue Growth Rate (2015-2025)
11 Global Motion Sickness Treatment Market Segment by Application
11.1 Global Motion Sickness Treatment Revenue Market Share by Application (2015-2020)
11.2 Motion Sickness Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global Motion Sickness Treatment Market Size Forecast (2021-2025)
12.1 Global Motion Sickness Treatment Market Size Forecast (2021-2025)
12.2 Global Motion Sickness Treatment Market Forecast by Regions (2021-2025)
12.3 North America Motion Sickness Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Motion Sickness Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Motion Sickness Treatment Revenue Market Forecast (2021-2025)
12.6 South America Motion Sickness Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Motion Sickness Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Motion Sickness Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Motion Sickness Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Motion Sickness Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Motion Sickness Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. GlaxoSmithKline Corporate Information, Location and Competitors
Table 6. GlaxoSmithKline Motion Sickness Treatment Major Business
Table 7. GlaxoSmithKline Motion Sickness Treatment Total Revenue (USD Million) (2017-2018)
Table 8. GlaxoSmithKline SWOT Analysis
Table 9. GlaxoSmithKline Motion Sickness Treatment Product and Solutions
Table 10. GlaxoSmithKline Motion Sickness Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Reliefband Technologies Corporate Information, Location and Competitors
Table 12. Reliefband Technologies Motion Sickness Treatment Major Business
Table 13. Reliefband Technologies Motion Sickness Treatment Total Revenue (USD Million) (2018-2019)
Table 14. Reliefband Technologies SWOT Analysis
Table 15. Reliefband Technologies Motion Sickness Treatment Product and Solutions
Table 16. Reliefband Technologies Motion Sickness Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. WellSpring Pharmaceutical Corporation Corporate Information, Location and Competitors
Table 18. WellSpring Pharmaceutical Corporation Motion Sickness Treatment Major Business
Table 19. WellSpring Pharmaceutical Corporation Motion Sickness Treatment Total Revenue (USD Million) (2017-2018)
Table 20. WellSpring Pharmaceutical Corporation SWOT Analysis
Table 21. WellSpring Pharmaceutical Corporation Motion Sickness Treatment Product and Solutions
Table 22. WellSpring Pharmaceutical Corporation Motion Sickness Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Perrigo Company Corporate Information, Location and Competitors
Table 24. Perrigo Company Motion Sickness Treatment Major Business
Table 25. Perrigo Company Motion Sickness Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Perrigo Company SWOT Analysis
Table 27. Perrigo Company Motion Sickness Treatment Product and Solutions
Table 28. Perrigo Company Motion Sickness Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Baxter International Corporate Information, Location and Competitors
Table 30. Baxter International Motion Sickness Treatment Major Business
Table 31. Baxter International Motion Sickness Treatment Total Revenue (USD Million) (2017-2018)
Table 32. Baxter International SWOT Analysis
Table 33. Baxter International Motion Sickness Treatment Product and Solutions
Table 34. Baxter International Motion Sickness Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Prestige Brands Corporate Information, Location and Competitors
Table 36. Prestige Brands Motion Sickness Treatment Major Business
Table 37. Prestige Brands Motion Sickness Treatment Total Revenue (USD Million) (2017-2018)
Table 38. Prestige Brands SWOT Analysis
Table 39. Prestige Brands Motion Sickness Treatment Product and Solutions
Table 40. Prestige Brands Motion Sickness Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Myungmoon Pharm Corporate Information, Location and Competitors
Table 42. Myungmoon Pharm Motion Sickness Treatment Major Business
Table 43. Myungmoon Pharm Motion Sickness Treatment Total Revenue (USD Million) (2017-2018)
Table 44. Myungmoon Pharm SWOT Analysis
Table 45. Myungmoon Pharm Motion Sickness Treatment Product and Solutions
Table 46. Myungmoon Pharm Motion Sickness Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Caleb Pharmaceuticals Corporate Information, Location and Competitors
Table 48. Caleb Pharmaceuticals Motion Sickness Treatment Major Business
Table 49. Caleb Pharmaceuticals Motion Sickness Treatment Total Revenue (USD Million) (2017-2018)
Table 50. Caleb Pharmaceuticals SWOT Analysis
Table 51. Caleb Pharmaceuticals Motion Sickness Treatment Product and Solutions
Table 52. Caleb Pharmaceuticals Motion Sickness Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Global Motion Sickness Treatment Revenue (Million USD) by Players (2015-2020)
Table 54. Global Motion Sickness Treatment Revenue Share by Players (2015-2020)
Table 55. Global Motion Sickness Treatment Revenue (Million USD) by Regions (2015-2020)
Table 56. Global Motion Sickness Treatment Revenue Market Share by Regions (2015-2020)
Table 57. North America Motion Sickness Treatment Revenue by Countries (2015-2020)
Table 58. North America Motion Sickness Treatment Revenue Market Share by Countries (2015-2020)
Table 59. Europe Motion Sickness Treatment Revenue (Million USD) by Countries (2015-2020)
Table 60. Asia-Pacific Motion Sickness Treatment Revenue (Million USD) by Countries (2015-2020)
Table 61. South America Motion Sickness Treatment Revenue by Countries (2015-2020)
Table 62. South America Motion Sickness Treatment Revenue Market Share by Countries (2015-2020)
Table 63. Middle East and Africa Motion Sickness Treatment Revenue (Million USD) by Countries (2015-2020)
Table 64. Middle East and Africa Motion Sickness Treatment Revenue Market Share by Countries (2015-2020)
Table 65. Global Motion Sickness Treatment Revenue (Million USD) by Type (2015-2020)
Table 66. Global Motion Sickness Treatment Revenue Share by Type (2015-2020)
Table 67. Global Motion Sickness Treatment Revenue Forecast by Type (2021-2025)
Table 68. Global Motion Sickness Treatment Revenue by Application (2015-2020)
Table 69. Global Motion Sickness Treatment Revenue Share by Application (2015-2020)
Table 70. Global Motion Sickness Treatment Revenue Forecast by Application (2021-2025)
Table 71. Global Motion Sickness Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Motion Sickness Treatment Picture
Figure 2. Global Motion Sickness Treatment Revenue Market Share by Type in 2019
Figure 3. Anticholinergic Picture
Figure 4. Antihistamines Picture
Figure 5. Others Picture
Figure 6. Motion Sickness Treatment Revenue Market Share by Application in 2019
Figure 7. Hospitals Picture
Figure 8. Clinics Picture
Figure 9. Other Picture
Figure 10. Global Motion Sickness Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Motion Sickness Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Motion Sickness Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Motion Sickness Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Motion Sickness Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Motion Sickness Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Motion Sickness Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Motion Sickness Treatment Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Motion Sickness Treatment Revenue Market Share in 2019
Figure 19. Global Top 10 Players Motion Sickness Treatment Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Motion Sickness Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Motion Sickness Treatment Revenue Market Share by Regions (2015-2020)
Figure 23. Global Motion Sickness Treatment Revenue Market Share by Regions in 2018
Figure 24. North America Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
Figure 25. Europe Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
Figure 27. South America Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
Figure 29. North America Motion Sickness Treatment Revenue Market Share by Countries (2015-2020)
Figure 30. North America Motion Sickness Treatment Revenue Market Share by Countries in 2019
Figure 31. USA Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
Figure 32. Canada Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
Figure 34. Europe Motion Sickness Treatment Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Motion Sickness Treatment Revenue Market Share by Countries in 2019
Figure 36. Germany Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
Figure 37. UK Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
Figure 38. France Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
Figure 39. Russia Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
Figure 40. Italy Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Motion Sickness Treatment Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Motion Sickness Treatment Revenue Market Share by Countries in 2019
Figure 43. China Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
Figure 44. Japan Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
Figure 45. Korea Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
Figure 46. India Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
Figure 48. South America Motion Sickness Treatment Revenue Market Share by Countries (2015-2020)
Figure 49. South America Motion Sickness Treatment Revenue Market Share by Countries in 2019
Figure 50. Brazil Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Motion Sickness Treatment Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Motion Sickness Treatment Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
Figure 55. UAE Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Motion Sickness Treatment Revenue and Growth Rate (2015-2020)
Figure 58. Global Motion Sickness Treatment Revenue Share by Type (2015-2020)
Figure 59. Global Motion Sickness Treatment Revenue Share by Type in 2019
Figure 60. Global Motion Sickness Treatment Market Share Forecast by Type (2021-2025)
Figure 61. Global Anticholinergic Revenue Growth Rate (2015-2020)
Figure 62. Global Antihistamines Revenue Growth Rate (2015-2020)
Figure 63. Global Others Revenue Growth Rate (2015-2020)
Figure 64. Global Motion Sickness Treatment Revenue Share by Application (2015-2020)
Figure 65. Global Motion Sickness Treatment Revenue Share by Application in 2019
Figure 66. Global Motion Sickness Treatment Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 68. Global Clinics Revenue Growth Rate (2015-2020)
Figure 69. Global Other Revenue Growth Rate (2015-2020)
Figure 70. Global Motion Sickness Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Motion Sickness Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Motion Sickness Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Motion Sickness Treatment Revenue Market Forecast (2021-2025)
Figure 74. Europe Motion Sickness Treatment Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Motion Sickness Treatment Revenue Market Forecast (2021-2025)
Figure 76. South America Motion Sickness Treatment Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Motion Sickness Treatment Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel

---